Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 78 | 9 | 0 | 0 | 12,605 |
| Cost of Goods | N/A | N/A | N/A | N/A | 9,920 |
| Gross Profit | 78 | 9 | N/A | N/A | 2,686 |
| Operating Expenses | 54,026 | 5,808 | 4,081 | 2,554 | 7,492 |
| Operating Income | -53,948 | -5,799 | -4,081 | -2,554 | -3,887 |
| Interest Expense | 0 | 0 | 0 | 5,231 | 1,243 |
| Other Income | -11,422 | 5,648 | 194 | 154 | -324 |
| Pre-tax Income | -65,370 | -151 | -3,887 | -7,631 | -5,454 |
| Income Tax | -15,248 | -52 | N/A | N/A | 3 |
| Net Income Continuous | -50,122 | -99 | -3,887 | -7,631 | -5,457 |
| Net Income Discontinuous | N/A | N/A | N/A | -333 | N/A |
| Net Income | $-50,122 | $-99 | $-3,887 | $-7,965 | $-5,457 |
| EPS Basic Total Ops | -28.81 | 0.00 | -0.84 | -1.56 | -1.32 |
| EPS Basic Continuous Ops | -28.64 | 0.00 | -0.82 | -1.44 | -1.30 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.12 | N/A |
| EPS Diluted Total Ops | -28.81 | -0.12 | -0.84 | -1.56 | -1.32 |
| EPS Diluted Continuous Ops | -28.64 | 0.00 | -0.82 | -1.44 | -1.30 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.12 | N/A |
| EBITDA(a) | $-53,756 | $-5,600 | $-3,845 | $-2,379 | $-3,195 |